These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39156790)

  • 21. Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier.
    Allen CL; Wolanska K; Malhi NK; Benest AV; Wood ME; Amoaku W; Torregrossa R; Whiteman M; Bates DO; Whatmore JL
    Front Cell Dev Biol; 2021; 9():724905. PubMed ID: 34557493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway.
    Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the influence of angiostatin intravitreal injection on vascular leakage in retina and iris of the experimental diabetic rats.
    Sima J; Ma J; Zhang SX; Guo J
    Yan Ke Xue Bao; 2006 Dec; 22(4):252-8. PubMed ID: 17378159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy.
    Zhao F; Gao X; Ge X; Cui J; Liu X
    Bioengineered; 2021 Dec; 12(2):9266-9278. PubMed ID: 34699316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
    Jiang H; Zhang H; Jiang X; Wu S
    Diabetologia; 2021 Mar; 64(3):693-706. PubMed ID: 33319325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study on the therapeutic effect and mechanism of erlotinib on non-proliferative diabetic retinopathy].
    Zhu MH; Zhao QL; Sun YK; Song E
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):906-918. PubMed ID: 37936359
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-34a promotes apoptosis of retinal vascular endothelial cells by targeting SIRT1 in rats with diabetic retinopathy.
    Ji Q; Han J; Wang L; Liu J; Dong Y; Zhu K; Shi L
    Cell Cycle; 2020 Nov; 19(21):2886-2896. PubMed ID: 33064974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
    Jiang S; Chen X
    Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
    Wang L; Wang N; Tan HY; Zhang Y; Feng Y
    J Ethnopharmacol; 2015 Jul; 169():295-304. PubMed ID: 25929449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.
    Chronopoulos A; Tang A; Beglova E; Trackman PC; Roy S
    Diabetes; 2010 Dec; 59(12):3159-66. PubMed ID: 20823103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.
    Xu H; Cai M; Zhang X
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1485-92. PubMed ID: 25371107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
    Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina.
    Yang QH; Zhang Y; Jiang J; Wu MM; Han Q; Bo QY; Yu GW; Ru YS; Liu X; Huang M; Wang L; Zhang XM; Fang JM; Li XR
    Int J Ophthalmol; 2018; 11(6):935-944. PubMed ID: 29977804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
    Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.